Two novel silver(I) phenanthroline derivatives complexes induces G2/M phase cycle arrest and apoptosis of MDA‐MB‐231 cancer cells by multiple mechanisms

Zong‐ling Niu,Tian‐Tian Wu,Yuan‐yuan Wu,Si‐Han Zhou,Zhe Li,Ji‐Chao Guo,Shu‐Min Zhou,Shi‐Hui Deng,Jing‐Yuan Xu,Ming‐Jin Xie
DOI: https://doi.org/10.1002/aoc.7123
IF: 3.9
2023-04-28
Applied Organometallic Chemistry
Abstract:Two novel silver(I) phenanthroline derivatives complexes (P‐235 and P‐239) have been been synthesized and characterized by IR, HPLC‐MS and 1HNMR. The cytotoxicity of two complexes were exhibited significant cytotoxicity against human breast cancer (MDA‐MB‐231) cell line (IC50 = 0.48 ± 0.01 and 0.12 ± 0.01 μM) and less toxicity than cisplatin by MTT assays. Furthermore, anticancer mechanistic studies showed P‐235 and P‐239 induced G2/M phase cell cycle arrest to inhibit the growth of MDA‐MB‐231 cells. Flow cytometry analysis showed that MDA‐MB‐231 cells could be significantly induced to undergo apoptosis by P‐235 and P‐239. And P‐235 and P‐239 induced apoptosis was linked with reactive oxygen species (ROS) production. The further study revealed that P‐235 and P‐239 cause mitochondrial membrane potential depolarization and destroy mitochondrial membrane potential.
chemistry, inorganic & nuclear, applied
What problem does this paper attempt to address?